• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    ADIPOCYTE DIFFERENTIATION
    September 12, 2021
    STIMULATED LIPOLYSYS
    September 12, 2021
    1. Metabolic reprogramming: the emerging concept and associated therapeutic strategies
    2. HIF1α and Metabolic reprogramming in inflammation
    3. Lipid Metabolic reprogramming in cancer cells
    4. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate
    5. Metabolic reprogramming of the tumor
    6. miRNAs link Metabolic reprogramming to oncogenesis
    7. Metabolic reprogramming of immune cells in cancer progression
    8. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
    9. Metabolic reprogramming and Metabolic dependency in T cells
    10. Metabolic reprogramming in glioma
    11. Oxygen availability and Metabolic reprogramming in cancer
    12. Lipid Metabolic reprogramming in hepatocellular carcinoma
    13. Metabolic reprogramming during neuronal differentiation
    14. Metabolic reprogramming of stem cell epigenetics
    15. The transcription factor Myc controls Metabolic reprogramming upon T lymphocyte activation
    16. Anti-inflammatory effect of IL-10 mediated by Metabolic reprogramming of macrophages
    17. Metabolic reprogramming, caloric restriction and aging
    18. Linking Metabolic reprogramming to therapy resistance in cancer
    19. Oncogenic regulation of tumor Metabolic reprogramming
    20. Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer
    21. Regulation of immune cell functions by Metabolic reprogramming
    22. Oxidative stress, tumor microenvironment, and Metabolic reprogramming: a diabolic liaison
    23. Metabolic reprogramming in macrophages and dendritic cells in innate immunity
    24. Metabolic reprogramming of the tumour microenvironment
    25. Cancer metabolism: key players in Metabolic reprogramming
    26. Contribution of Metabolic reprogramming to macrophage plasticity and function
    27. Reciprocal Metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay
    28. Metabolic reprogramming by class I and II histone deacetylases
    29. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis
    30. Dysregulated Metabolic enzymes and Metabolic reprogramming in cancer cells
    31. Control of nutrient stress-induced Metabolic reprogramming by PKCζ in tumorigenesis
    32. Metabolic reprogramming by viruses in the sunlit and dark ocean
    33. Energy Metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach
    34. Viral Metabolic reprogramming in marine ecosystems
    35. Metabolic reprogramming in brain tumors
    36. Clinical significance of T cell Metabolic reprogramming in cancer
    37. Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation
    38. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
    39. mTORC2 in the center of cancer Metabolic reprogramming
    40. Metabolic reprogramming of periwinkle plant culture
    41. Metabolic reprogramming in clear cell renal cell carcinoma
    42. Influence of the tumor microenvironment on cancer cells Metabolic reprogramming
    43. Cancer Metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
    44. The autophagy conundrum in cancer: influence of tumorigenic Metabolic reprogramming
    45. Analysis of hypoxia-induced Metabolic reprogramming
    46. Molecular drivers of cellular Metabolic reprogramming in melanoma
    47. The role of YAP/TAZ activity in cancer Metabolic reprogramming
    48. Global Metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC
    49. Metabolic reprogramming: a hallmark of viral oncogenesis
    50. Metabolic reprogramming and tolerance during sepsis-induced AKI
    51. Metabolic reprogramming by the PI3K-Akt-mTOR pathway in cancer
    52. PDK1-dependent Metabolic reprogramming dictates metastatic potential in breast cancer
    53. Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
    54. Nrf2 redirects glucose and glutamine into anabolic pathways in Metabolic reprogramming
    55. Metabolic reprogramming supports IFN-γ production by CD56bright NK cells
    56. Genetically-defined Metabolic reprogramming in cancer
    57. Cell-autonomous Metabolic reprogramming in hypoxia
    58. A role for the Krebs cycle intermediate citrate in Metabolic reprogramming in innate immunity and inflammation
    59. Targeting Metabolic reprogramming in KRAS-driven cancers
    60. Targeting Metabolic reprogramming by influenza infection for therapeutic intervention
    61. ADHFE1 is a breast cancer oncogene and induces Metabolic reprogramming
    62. Metabolic reprogramming in amyotrophic lateral sclerosis
    63. Metabolic reprogramming in chloroplasts under heat stress in plants
    64. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
    65. Similarities in the Metabolic reprogramming of immune system and endothelium
    66. Akt-dependent Metabolic reprogramming regulates tumor cell histone acetylation
    67. Novel drugs that target the Metabolic reprogramming in renal cell cancer
    68. Tissue-specific Metabolic reprogramming drives nutrient flux in diabetic complications
    69. Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation
    70. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
    71. mTORC1-dependent Metabolic reprogramming is a prerequisite for NK cell effector function
    72. Autophagy in stem cells: repair, remodelling and Metabolic reprogramming
    73. Control of amino-acid transport by antigen receptors coordinates the Metabolic reprogramming essential for T cell differentiation
    74. Metabolic reprogramming is required for myofibroblast contractility and differentiation
    75. Grade-dependent Metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis
    76. Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
    77. Metabolic reprogramming in dietary restriction
    78. Nrf2-mediated Metabolic reprogramming in cancer
    79. The role of Metabolic reprogramming in T cell fate and function
    80. Metabolic reprogramming in thyroid carcinoma
    81. Initial B cell activation induces Metabolic reprogramming and mitochondrial remodeling
    82. Molecular mechanisms of Metabolic reprogramming in proliferating cells: implications for T‐cell‐mediated immunity
    83. Mutant Kras copy number defines Metabolic reprogramming and therapeutic susceptibilities
    84. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
    85. The emerging “hallmarks” of Metabolic reprogramming and immune evasion: distinct or linked?
    86. IAPP-driven Metabolic reprogramming induces regression of p53-deficient tumours in vivo
    87. Metabolic reprogramming during the Trypanosoma brucei life cycle
    88. The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
    89. Metabolic reprogramming of cancer associated fibroblasts: the slavery of stromal fibroblasts
    90. Metabolic reprogramming supports the invasive phenotype in malignant melanoma
    91. The effect of immunosuppressive molecules on T-cell Metabolic reprogramming
    92. Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation
    93. Translational and HIF-1α-dependent Metabolic reprogramming underpin Metabolic plasticity and responses to kinase inhibitors and biguanides
    94. Metabolic reprogramming of host cells upon bacterial infection: Why shift to a Warburg‐like metabolism?
    95. Metabolomics and Metabolic reprogramming in kidney cancer
    96. Metabolic reprogramming of mitochondrial respiration in metastatic cancer
    97. Targeting the Metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors
    98. Metabolic reprogramming as a novel regulator of skeletal muscle development and regeneration
    99. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype
    100. Biomarkers of coordinate Metabolic reprogramming in colorectal tumors in mice and humans
    101. Mitochondrial Metabolic reprogramming induced by calorie restriction
    102. TLR-mediated Metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
    103. Complement regulates nutrient influx and Metabolic reprogramming during Th1 cell responses
    104. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells
    105. Metabolic reprogramming in modulating T cell reactive oxygen species generation and antioxidant capacity
    106. Role of SLC7A5 in Metabolic reprogramming of human monocyte/macrophage immune responses
    107. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes
    108. Reciprocal regulation of Metabolic reprogramming and epigenetic modifications in cancer
    109. BNIP3L/NIX-dependent mitophagy regulates cell differentiation via Metabolic reprogramming
    110. Metabolic reprogramming in plant innate immunity: the contributions of phenylpropanoid and oxylipin pathways
    111. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
    112. Metabolic reprogramming of non-Hodgkin’s B-cell lymphomas and potential therapeutic strategies
    113. Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to Metabolic inhibition in CD8 versus CD4 T …
    114. Mitofusins deficiency elicits mitochondrial Metabolic reprogramming to pluripotency
    115. VEGF‐B‐induced vascular growth leads to Metabolic reprogramming and ischemia resistance in the heart
    116. Human dendritic cell subsets undergo distinct Metabolic reprogramming for immune response
    117. xCT (SLC7A11)-mediated Metabolic reprogramming promotes non-small cell lung cancer progression
    118. Loss of the tumor suppressor LKB1 promotes Metabolic reprogramming of cancer cells via HIF-1α
    119. T cell Metabolic reprogramming and plasticity
    120. PD-1 alters T-cell Metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
    121. LPA induces Metabolic reprogramming in ovarian cancer via a pseudohypoxic response
    122. HIF-1-mediated Metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs
    123. Metabolic reprogramming in type 2 diabetes and the development of breast cancer
    124. Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade
    125. Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation
    126. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
    127. Metabolic reprogramming in mutant IDH1 glioma cells
    128. Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on Metabolic heterogeneity of tumors
    129. Alterations in the vaginal microbiome by maternal stress are associated with Metabolic reprogramming of the offspring gut and brain
    130. Role of mesenchymal stem cells in osteosarcoma and Metabolic reprogramming of tumor cells
    131. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated Metabolic reprogramming
    132. Glycosphingolipid Metabolic reprogramming drives neural differentiation
    133. Metabolic reprogramming & inflammation: Fuelling the host response to pathogens
    134. Metabolic reprogramming of pancreatic cancer mediated by CDK4/6 inhibition elicits unique vulnerabilities
    135. Inflammation-modulated Metabolic reprogramming is required for DUOX-dependent gut immunity in Drosophila
    136. Quantitative H2S-mediated protein sulfhydration reveals Metabolic reprogramming during the integrated stress response
    137. Myokine mediated muscle-kidney crosstalk suppresses Metabolic reprogramming and fibrosis in damaged kidneys
    138. Deregulated Myc requires MondoA/Mlx for Metabolic reprogramming and tumorigenesis
    139. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
    140. On Metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
    141. Fatty acid Metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells
    142. Metabolic reprogramming and longevity of tissue-resident memory T cells
    143. Aldolase B-mediated fructose metabolism drives Metabolic reprogramming of colon cancer liver metastasis
    144. “Metabolic reprogramming” in ovarian cancer cells resistant to cisplatin
    145. Store-operated Ca2+ entry controls clonal expansion of T cells through Metabolic reprogramming
    146. mTORC1-dependent Metabolic reprogramming underlies escape from glycolysis addiction in cancer cells
    147. Hallmarks of pulmonary hypertension: mesenchymal and inflammatory cell Metabolic reprogramming
    148. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
    149. Molecular pathways: targeting MYC-induced Metabolic reprogramming and oncogenic stress in cancer
    150. Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis
    151. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment
    152. Placental Metabolic reprogramming: do changes in the mix of energy-generating substrates modulate fetal growth?
    153. Branched chain amino acid Metabolic reprogramming in heart failure
    154. GFPT2-expressing cancer-associated fibroblasts mediate Metabolic reprogramming in human lung adenocarcinoma
    155. ATM couples replication stress and Metabolic reprogramming during cellular senescence
    156. Nrf2 negatively regulates STING indicating a link between antiviral sensing and Metabolic reprogramming
    157. IL-23 and IL-1β drive human Th17 cell differentiation and Metabolic reprogramming in absence of CD28 costimulation
    158. Metformin-induced Metabolic reprogramming of chemoresistant ALDHbright breast cancer cells
    159. BCAT1 controls Metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases
    160. Targeting Metabolic reprogramming as a potential therapeutic strategy in melanoma
    161. Coactivator SRC-2–dependent Metabolic reprogramming mediates prostate cancer survival and metastasis
    162. Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment
    163. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia
    164. Oncogenic KRAS and BRAF drive Metabolic reprogramming in colorectal cancer
    165. Modelling central Metabolic fluxes by constraint‐based optimization reveals Metabolic reprogramming of developing Solanum lycopersicum (tomato) fruit
    166. Metabolic reprogramming of the tumor microenvironment by p62 and its partners
    167. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis
    168. Starvation signals in yeast are integrated to coordinate Metabolic reprogramming and stress response to ensure longevity
    169. Oxidative modifications of glyceraldehyde 3-phosphate dehydrogenase regulate Metabolic reprogramming of stored red blood cells
    170. Jasmonate signaling involves the abscisic acid receptor PYL4 to regulate Metabolic reprogramming in Arabidopsis and tobacco
    171. MicroRNAs and oncogenic transcriptional regulatory networks controlling Metabolic reprogramming in cancers
    172. Oxidative dimerization of PHD2 is responsible for its inactivation and contributes to Metabolic reprogramming via HIF-1α activation
    173. A key role for transketolase-like 1 in tumor Metabolic reprogramming
    174. Oxidative stress and Metabolic reprogramming in Cr (VI) carcinogenesis
    175. HIF-1α is required for disturbed flow-induced Metabolic reprogramming in human and porcine vascular endothelium
    176. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated Metabolic reprogramming
    177. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension
    178. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent Metabolic reprogramming
    179. Loss of GLUT4 induces Metabolic reprogramming and impairs viability of breast cancer cells
    180. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent Metabolic reprogramming of stromal cells
    181. Chronic inflammation confers to the Metabolic reprogramming associated with tumorigenesis of colorectal cancer
    182. Interferon gamma induces reversible Metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity
    183. Ionizing radiation impairs T cell activation by affecting Metabolic reprogramming
    184. Metabolomics of oncogene-specific Metabolic reprogramming during breast cancer
    185. NOX4 functions as a mitochondrial energetic sensor coupling cancer Metabolic reprogramming to drug resistance
    186. Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases
    187. Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment
    188. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA
    189. Targeting lipid Metabolic reprogramming as anticancer therapeutics
    190. ATF4 regulates CD4+ T cell immune responses through Metabolic reprogramming
    191. Metabolic reprogramming and dependencies associated with epithelial cancer stem cells independent of the epithelial‐mesenchymal transition program
    192. Nitric oxide triggers a transient Metabolic reprogramming in Arabidopsis
    193. Quantitative Proteomics of Intracellular Campylobacter jejuni Reveals Metabolic reprogramming
    194. Switching of pyruvate kinase isoform L to M2 promotes Metabolic reprogramming in hepatocarcinogenesis
    195. Redox regulation of the epigenetic landscape in cancer: a role for Metabolic reprogramming in remodeling the epigenome
    196. Metabolic reprogramming during multidrug resistance in Leukemias
    197. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
    198. TPO-induced Metabolic reprogramming drives liver metastasis of colorectal cancer CD110+ tumor-initiating cells
    199. Elicitor-induced transcription factors for Metabolic reprogramming of secondary metabolism in Medicago truncatula
    200. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with “Warburg-like” cancer metabolism and L …
    201. SIRT3 controls cancer Metabolic reprogramming by regulating ROS and HIF
    202. … stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell–like Metabolic reprogramming
    203. Metabolic reprogramming in polycystic kidney disease
    204. Comprehensive proteomics analysis reveals Metabolic reprogramming of tumor-associated macrophages stimulated by the tumor microenvironment
    205. Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated Metabolic reprogramming
    206. Metabolic reprogramming of human CD8+ memory T cells through loss of SIRT1
    207. White-to-brite conversion in human adipocytes promotes Metabolic reprogramming towards fatty acid anabolic and catabolic pathways
    208. Metabolic reprogramming of the heart through stearoyl-CoA desaturase
    209. Disruption of cytochrome c oxidase function induces the Warburg effect and Metabolic reprogramming
    210. Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by Metabolic reprogramming
    211. Transcriptional and Translational Downregulation of Thioredoxin Interacting Protein Is Required for Metabolic reprogramming during G1
    212. Mitochondrial pyruvate carrier function determines cell stemness and Metabolic reprogramming in cancer cells
    213. Lactate inhibits the pro-inflammatory response and Metabolic reprogramming in murine macrophages in a GPR81-independent manner
    214. Improper excess light energy dissipation in Arabidopsis results in a Metabolic reprogramming
    215. Protein kinase C-β dictates B cell fate by regulating mitochondrial remodeling, Metabolic reprogramming, and heme biosynthesis
    216. Transforming growth factor-β induced Warburg-like Metabolic reprogramming may underpin the development of peritoneal endometriosis
    217. DJ-1 links muscle ROS production with Metabolic reprogramming and systemic energy homeostasis in mice
    218. Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer
    219. Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated Metabolic reprogramming
    220. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis
    221. Metabolic reprogramming of Clostridioides difficile during the stationary phase with the induction of toxin production
    222. Quantitative proteomics by SWATH-MS reveals sophisticated Metabolic reprogramming in hepatocellular carcinoma tissues
    223. The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell Metabolic reprogramming and proliferation
    224. Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma
    225. Drp1 controls effective T cell immune-surveillance by regulating T cell migration, proliferation, and cMyc-dependent Metabolic reprogramming
    226. Transcriptional and Metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages
    227. KPNA2 promotes Metabolic reprogramming in glioblastomas by regulation of c-myc
    228. Metabolic reprogramming by dual AKT/ERK inhibition through imipridones elicits unique vulnerabilities in glioblastoma
    229. Metabolic reprogramming during Purine Stress in the Protozoan Pathogen Leishmania donovani
    230. Autophagy-dependent Metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide
    231. Transcription factor RD 26 is a key regulator of Metabolic reprogramming during dark‐induced senescence
    232. Metabolic reprogramming by folate restriction leads to a less aggressive cancer phenotype
    233. EWS/FLI is a master regulator of Metabolic reprogramming in Ewing sarcoma
    234. Crosstalk between two bZIP signaling pathways orchestrates salt-induced Metabolic reprogramming in Arabidopsis roots
    235. Metabolic reprogramming and oncogenesis: one hallmark, many organelles
    236. Environmental Toxin–Linked Nonalcoholic Steatohepatitis and Hepatic Metabolic reprogramming in Obese Mice
    237. Lactobacillus johnsonii supplementation attenuates respiratory viral infection via Metabolic reprogramming and immune cell modulation
    238. Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated Metabolic reprogramming and angiogenesis
    239. The mitochondrial Metabolic reprogramming agent trimetazidine as an ‘exercise mimetic’in cachectic C26‐bearing mice
    240. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
    241. Metabolic reprogramming and two-compartment tumor metabolism: opposing role (s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer …
    242. Arginine deiminase resistance in melanoma cells is associated with Metabolic reprogramming, glucose dependence, and glutamine addiction
    243. Lsd1 ablation triggers Metabolic reprogramming of brown adipose tissue
    244. Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread Metabolic reprogramming
    245. Including the mitochondrial metabolism of L-lactate in cancer Metabolic reprogramming
    246. Dose-dependent Metabolic reprogramming and differential gene expression in TCDD-elicited hepatic fibrosis
    247. Acute loss of iron–sulfur clusters results in Metabolic reprogramming and generation of lipid droplets in mammalian cells
    248. Metabolic reprogramming in keloid fibroblasts: aerobic glycolysis and a novel therapeutic strategy
    249. Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation
    250. mTORC1 promotes Metabolic reprogramming by the suppression of GSK3-dependent Foxk1 phosphorylation
    251. Metabolic reprogramming and the recovery of physiological functionality in 3D cultures in micro-bioreactors
    252. Isotopically nonstationary 13C flux analysis of Myc-induced Metabolic reprogramming in B-cells
    253. Noncoding RNAs in regulation of cancer Metabolic reprogramming
    254. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma
    255. Model-driven discovery of long-chain fatty acid Metabolic reprogramming in heterogeneous prostate cancer cells
    256. PKM2-dependent Metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis
    257. Caught in the cROSsfire: GSH controls T cell Metabolic reprogramming
    258. Dissection of Metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways
    259. Nrf2 is a central regulator of Metabolic reprogramming of myeloid-derived suppressor cells in steady state and sepsis
    260. Hydrogen peroxide stress provokes a Metabolic reprogramming in Pseudomonas fluorescens: enhanced production of pyruvate
    261. Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia
    262. Homocysteine activates B cells via regulating PKM2-dependent Metabolic reprogramming
    263. Tracking down the origin of cancer: Metabolic reprogramming as a driver of stemness and tumorigenesis
    264. The mitochondrial H+-ATP synthase and the lipogenic switch: New core components of Metabolic reprogramming in induced pluripotent stem (iPS) cells
    265. Metabolic reprogramming by HIF-1 promotes the survival of bone marrow–derived angiogenic cells in ischemic tissue
    266. Control of amino acid transport coordinates Metabolic reprogramming in T-cell malignancy
    267. Metabolic reprogramming in the heart and lung in a murine model of pulmonary arterial hypertension
    268. Metabolic reprogramming and Validation of Hyperpolarized 13C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor
    269. Metabolic reprogramming in leaf lettuce grown under different light quality and intensity conditions using narrow-band LEDs
    270. Metabolic reprogramming commits differentiation of human CD27+ IgD+ B cells to plasmablasts or CD27− IgD− cells
    271. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells
    272. Photoreceptor Metabolic reprogramming provides survival advantage in acute stress while causing chronic degeneration
    273. AMPK Activation and Metabolic reprogramming by Tamoxifen through Estrogen Receptor–Independent Mechanisms Suggests New Uses for This Therapeutic …
    274. GLUT3 upregulation promotes Metabolic reprogramming associated with antiangiogenic therapy resistance
    275. Resveratrol impedes the stemness, epithelial-mesenchymal transition, and Metabolic reprogramming of cancer stem cells in nasopharyngeal carcinoma …
    276. Lipid Metabolic reprogramming in hepatic ischemia–reperfusion injury
    277. mTORC2 and Metabolic reprogramming in GBM: at the interface of genetics and environment
    278. The role of Metabolic reprogramming in γ‐herpesvirus‐associated oncogenesis
    279. Metabolic reprogramming by hexosamine biosynthetic and Golgi N-glycan branching pathways
    280. Hypoxic repression of pyruvate dehydrogenase activity is necessary for Metabolic reprogramming and growth of model tumours
    281. Autophagic reliance promotes Metabolic reprogramming in oncogenic KRAS-driven tumorigenesis
    282. Bergapten induces Metabolic reprogramming in breast cancer cells
    283. Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell Metabolic reprogramming and correlate with poor patient outcome
    284. TRAF3 deficiency promotes Metabolic reprogramming in B cells
    285. Silibinin-mediated Metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
    286. Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic Metabolic reprogramming in triple negative breast cancer
    287. DNMT1 mediates Metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma
    288. Integrated metabolomics and lipidomics analyses reveal Metabolic reprogramming in human glioma with IDH1 mutation
    289. Reconstructed Metabolic network models predict flux-level Metabolic reprogramming in glioblastoma
    290. Butyrate suppresses the proliferation of colorectal cancer cells via targeting pyruvate kinase M2 and Metabolic reprogramming
    291. Emerging function of mTORC2 as a core regulator in glioblastoma: Metabolic reprogramming and drug resistance
    292. Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid Metabolic reprogramming
    293. Metabolic reprogramming by the pyruvate dehydrogenase kinase–lactic acid axis: Linking metabolism and diverse neuropathophysiologies
    294. Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic Metabolic reprogramming in sickle cell disease
    295. The TORC1-regulated CPA complex rewires an RNA processing network to drive autophagy and Metabolic reprogramming
    296. Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent Metabolic reprogramming
    297. Metabolic reprogramming by 3-iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression
    298. Quantitative 1 H NMR metabolomics reveals extensive Metabolic reprogramming of primary and secondary metabolism in elicitor-treated opium poppy cell …
    299. Metabolic reprogramming and apoptosis sensitivity: Defining the contours of a T cell response
    300. Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
    301. SOCS1 is a negative regulator of Metabolic reprogramming during sepsis
    302. Critical roles of mTORC1 signaling and Metabolic reprogramming for M-CSF–mediated myelopoiesis
    303. Epidemiological-molecular evidence of Metabolic reprogramming on proliferation, autophagy and cell signaling in pancreas cancer
    304. Paracoccidioides brasiliensis presents Metabolic reprogramming and secretes a serine proteinase during murine infection
    305. Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo
    306. Metabolic reprogramming of Macrophages Exposed to Silk, Poly(lactic‐co‐glycolic acid), and Silica Nanoparticles
    307. Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities
    308. Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional …
    309. miR-155 drives Metabolic reprogramming of ER+ breast cancer cells following long-term estrogen deprivation and predicts clinical response to aromatase inhibitors
    310. A novel and safe small molecule enhances hair follicle regeneration by facilitating Metabolic reprogramming
    311. Phosphorus and iron deficiencies induce a Metabolic reprogramming and affect the exudation traits of the woody plant Fragaria×ananassa
    312. The impact of Metabolic reprogramming on dendritic cell function
    313. New insight into the role of Metabolic reprogramming in melanoma cells harboring BRAF mutations
    314. Pyruvate imbalance mediates Metabolic reprogramming and mimics lifespan extension by dietary restriction in Caenorhabditis elegans
    315. The Metabolic reprogramming Evoked by Nitrosative Stress Triggers the Anaerobic Utilization of Citrate in Pseudomonas fluorescens
    316. Fusarium oxysporum mediates systems Metabolic reprogramming of chickpea roots as revealed by a combination of proteomics and metabolomics
    317. Inflexibility of AMPK-mediated Metabolic reprogramming in mitochondrial disease
    318. Does Metabolic reprogramming underpin age-associated changes in T cell phenotype and function?
    319. Relationship between Metabolic reprogramming and mitochondrial activity in cancer cells. Understanding the anticancer effect of metformin and its clinical …
    320. Metabolic reprogramming under microaerobic and anaerobic conditions in bacteria
    321. The airway epithelium undergoes Metabolic reprogramming in individuals at high risk for lung cancer
    322. Testicular Metabolic reprogramming in neonatal streptozotocin-induced type 2 diabetic rats impairs glycolytic flux and promotes glycogen synthesis
    323. Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to …
    324. The environmental carcinogen benzo [a] pyrene induces a Warburg-like Metabolic reprogramming dependent on NHE1 and associated with cell survival
    325. CD73 on T cells orchestrates cardiac wound healing after myocardial infarction by purinergic Metabolic reprogramming
    326. Deep quantitative proteomics reveals extensive Metabolic reprogramming and cancer-like changes of ectopic endometriotic stromal cells
    327. LSD1 mediates Metabolic reprogramming by glucocorticoids during myogenic differentiation
    328. Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic Metabolic reprogramming in a mouse model of Gulf War …
    329. Hypothalamic responses to fasting indicate Metabolic reprogramming away from glycolysis toward lipid oxidation
    330. … RNAs enforce their will on mitochondrial activity: regulation of mitochondrial respiration, reactive oxygen species production, apoptosis, and Metabolic reprogramming …
    331. Antagonistic role of natural compounds in mTOR-mediated Metabolic reprogramming
    332. Cinnamaldehyde induces fat cell-autonomous thermogenesis and Metabolic reprogramming
    333. Photoperiod extension enhances sexual megaspore formation and triggers Metabolic reprogramming in facultative apomictic Ranunculus auricomus
    334. Metabolism and development–integration of micro computed tomography data and metabolite profiling reveals Metabolic reprogramming from floral initiation to silique …
    335. Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: from metabolomics to epigenetics
    336. Eukaryotic translation initiation factor 5A2 promotes Metabolic reprogramming in hepatocellular carcinoma cells
    337. Cooperative STAT/NF-κB signaling regulates lymphoma Metabolic reprogramming and aberrant GOT2 expression
    338. Fecal microbiota transplantation in experimental ulcerative colitis reveals associated gut microbial and host Metabolic reprogramming
    339. Pyruvate Kinase Isoform Switching and Hepatic Metabolic reprogramming by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
    340. Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia
    341. Impact of chemotherapy on Metabolic reprogramming: Characterization of the Metabolic profile of breast cancer MDA-MB-231 cells using 1H HR-MAS NMR …
    342. Metabolic reprogramming of murine cardiomyocytes during autophagy requires the extracellular nutrient sensor decorin
    343. Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent Metabolic reprogramming
    344. Acclimation-induced Metabolic reprogramming contributes to rapid desiccation tolerance acquisition in Boea hygrometrica
    345. Nrf2 promotes oesophageal cancer cell proliferation via Metabolic reprogramming and detoxification of reactive oxygen species
    346. EZH2 promotes Metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
    347. Metabolic reprogramming by HIF‐1 activation enhances survivability of human adipose‐derived stem cells in ischaemic microenvironments
    348. The platelet isoform of phosphofructokinase contributes to Metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma
    349. Inhibitor of differentiation 1 transcription factor promotes Metabolic reprogramming in hepatocellular carcinoma cells
    350. Dynamin 2-dependent endocytosis sustains T-cell receptor signaling and drives Metabolic reprogramming in T lymphocytes
    351. Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK–mediated phosphorylation of PKM2 and Metabolic reprogramming in anaplastic large cell …
    352. Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation‐induced T cell Metabolic reprogramming
    353. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated Metabolic reprogramming and ROS detoxification
    354. The role of HIF-1 in oncostatin M-dependent Metabolic reprogramming of hepatic cells
    355. Cell Stress, Metabolic reprogramming, and Cancer
    356. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial Metabolic reprogramming
    357. Metabolic reprogramming of host cells by virulent Francisella tularensis for optimal replication and modulation of inflammation
    358. Cigarette smoke induces mitochondrial Metabolic reprogramming in lung cells
    359. Metformin and caffeic acid regulate Metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell …
    360. Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled Metabolic reprogramming
    361. … of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting Metabolic reprogramming …
    362. … 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent Metabolic reprogramming
    363. … cascade‐triggered overexpression of CEMIP promotes migration and invasion in anoikis‐resistant prostate cancer cells by enhancing Metabolic reprogramming
    364. Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline
    365. UCP2 induces Metabolic reprogramming to inhibit proliferation of cancer cells
    366. HMGA1 drives Metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis
    367. CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and Metabolic reprogramming
    368. Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects Metabolic reprogramming and effectively inhibits cancer stem cells in Taxol® …
    369. PPARα antagonist AA452 triggers Metabolic reprogramming and increases sensitivity to radiation therapy in human glioblastoma primary cells
    370. Interscapular brown adipose tissue Metabolic reprogramming during cold acclimation: Interplay of HIF-1α and AMPKα
    371. 1H NMR Spectroscopy Profiling of Metabolic reprogramming of Chinese Hamster Ovary Cells upon a Temperature Shift during Culture
    372. Dynamic Metabolic reprogramming of steroidal glycol-alkaloid and phenylpropanoid biosynthesis may impart early blight resistance in wild tomato (Solanum arcanum …
    373. Mitochondrial mechanisms of Metabolic reprogramming in proliferating cells
    374. Toll‐like receptor 3 stimulation triggers Metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF
    375. Nrf2-mediated Metabolic reprogramming of tolerogenic dendritic cells is protective against aplastic anemia
    376. … 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer Metabolic reprogramming
    377. Metastatic cancer cells compensate for low energy supplies in hostile microenvironments with bioenergetic adaptation and Metabolic reprogramming
    378. Resveratrol stimulates the Metabolic reprogramming of human CD4+ T cells to enhance effector function
    379. δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and Metabolic reprogramming
    380. Indoleamine 2, 3-dioxygenase regulates anti-tumor immunity in lung cancer by Metabolic reprogramming of immune cells in the tumor microenvironment
    381. Compartment-specific activation of PPARγ governs breast cancer tumor growth, via Metabolic reprogramming and symbiosis
    382. Quantitative 1H-NMR-Metabolomics Reveals Extensive Metabolic reprogramming and the Effect of the Aquaglyceroporin FPS1 in Ethanol-Stressed Yeast …
    383. Differential gene expression pattern in hypothalamus of chickens during fasting-induced Metabolic reprogramming: Functions of glucose and lipid metabolism …
    384. Recent advances in the role of AMP-activated protein kinase in Metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic …
    385. Antioxidant modifications induced by the new metformin derivative HL156A regulate Metabolic reprogramming in SAMP1/kl (-/-) mice
    386. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma Metabolic reprogramming: Trichostatin A as a case study
    387. Quantitative proteomics suggests Metabolic reprogramming during ETHE1 deficiency
    388. FGF9‐induced ovarian cancer cell invasion involves VEGF‐A/VEGFR2 augmentation by virtue of ETS1 upregulation and Metabolic reprogramming
    389. Mitochondrial resetting and Metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling
    390. Hepatic glucose-6-phosphatase-α deficiency leads to Metabolic reprogramming in glycogen storage disease type Ia
    391. Metabolic reprogramming and redox signaling in pulmonary hypertension
    392. Pluripotency transcription factors and Metabolic reprogramming of mitochondria in tumor-initiating stem-like cells
    393. Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating Metabolic reprogramming
    394. Cell surface GRP78 promotes tumor cell histone acetylation through Metabolic reprogramming: a mechanism which modulates the Warburg effect
    395. Metabolic reprogramming and cell fate regulation in alcoholic liver disease
    396. Estradiol-17β upregulates pyruvate kinase M2 expression to coactivate estrogen receptor-α and to integrate Metabolic reprogramming with the mitogenic response in …
    397. Investigate the Metabolic reprogramming of Saccharomyces cerevisiae for Enhanced Resistance to Mixed Fermentation Inhibitors via 13C Metabolic Flux …
    398. Untargeted metabolomics reveals distinct Metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell …
    399. miR-125b regulates differentiation and Metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20
    400. Metabolic reprogramming in cancer: the art of balance
    401. Stimulation of the toll-like receptor 3 promotes Metabolic reprogramming in head and neck carcinoma cells
    402. ADHFE1 is a MYC-linked oncogene that induces Metabolic reprogramming and cellular de-differentiation in breast cancer
    403. Defects in the mitochondrial-tRNA modification enzymes MTO1 and GTPBP3 promote different Metabolic reprogramming through a HIF-PPARγ-UCP2-AMPK …
    404. Evaluation of mitochondrial function and Metabolic reprogramming during tumor progression in a cell model of skin carcinogenesis
    405. Candida albicans induces Metabolic reprogramming in human NK cells and responds to perforin with a zinc depletion response
    406. Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of Metabolic reprogramming in counterregulatory failure
    407. Metabolic reprogramming of Vibrio cholerae impaired in respiratory NADH oxidation is accompanied by increased copper sensitivity
    408. Mammalian SWI/SNF enzymes and the epigenetics of tumor cell Metabolic reprogramming
    409. Arsenic hyperaccumulation induces Metabolic reprogramming in Pityrogramma calomelanos to reduce oxidative stress
    410. Reply to Yoshida: Liver cancer stem cells: Identification and lipid Metabolic reprogramming
    411. Metabolic reprogramming, autophagy, and reactive oxygen species are necessary for primordial germ cell reprogramming into pluripotency
    412. Regulation of SIRT3 signal related Metabolic reprogramming in gastric cancer by Helicobacter pylori oncoprotein CagA
    413. Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
    414. Metabolic reprogramming in transformed mouse cortical astrocytes: A proteomic study
    415. Statin-induced Metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
    416. PDHA1 gene knockout in prostate cancer cells results in Metabolic reprogramming towards greater glutamine dependence
    417. mTORC2 contributes to the Metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer
    418. Metabolic reprogramming of the immune response in the tumor microenvironment
    419. 2‐methoxyestradiol impacts on amino acids‐mediated Metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor
    420. Clinically relevant HIF-1α-dependent Metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the …
    421. The miRNAome dynamics during developmental and Metabolic reprogramming of tomato root infected with potato cyst nematode
    422. Body mass index is associated with region-dependent Metabolic reprogramming of adipose tissue
    423. A systems analysis with “simplified source-sink model” reveals Metabolic reprogramming in a pair of source-to-sink organs during early fruit development in …
    424. The cell cycle regulator 14-3-3σ opposes and reverses cancer Metabolic reprogramming
    425. New insights into Behçet’s syndrome Metabolic reprogramming: citrate pathway dysregulation
    426. Post-transcriptional regulation of gene expression in response to iron deficiency: co-ordinated Metabolic reprogramming by yeast mRNA-binding proteins
    427. Metabolic reprogramming in disseminated cells
    428. MTOR-Driven Metabolic reprogramming Regulates Legionella pneumophila Intracellular Niche Homeostasis
    429. Uncoupling protein 2 regulates Metabolic reprogramming and fate of antigen-stimulated CD8+ T cells
    430. Detachment from the primary site and suspension in ascites as the initial step in Metabolic reprogramming and metastasis to the omentum in ovarian cancer
    431. Canceromics studies unravel tumor’s glutamine addiction after Metabolic reprogramming
    432. Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells
    433. Nrf2 and AhR in Metabolic reprogramming after contaminant exposure
    434. Systematic investigation of Metabolic reprogramming in different cancers based on tissue-specific Metabolic models
    435. Integrated omics-analysis reveals Wnt-mediated NAD+ Metabolic reprogramming in cancer stem-like cells
    436. Feeling energetic? New strategies to prevent Metabolic reprogramming in melanoma
    437. Combined metabonomic and quantitative RT-PCR analyses revealed Metabolic reprogramming associated with Fusarium graminearum resistance in …
    438. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway
    439. GLUT1, MCT1/4 and CD147 overexpression supports the Metabolic reprogramming in papillary renal cell carcinoma
    440. The phosphatidylinositol 3, 5-bisphosphate (PI (3, 5) P2)-dependent Tup1 conversion (PIPTC) regulates Metabolic reprogramming from glycolysis to gluconeogenesis
    441. Human iPSCs harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining hESC-like Metabolic reprogramming
    442. Small, Thin Graphene Oxide Is Anti-inflammatory Activating Nuclear Factor Erythroid 2-Related Factor 2 via Metabolic reprogramming
    443. Distinct physiological and Metabolic reprogramming by highbush blueberry (Vaccinium corymbosum) cultivars revealed during long‐term UV‐B radiation
    444. Erratum to: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
    445. AMBRA1 is involved in T cell receptor-mediated Metabolic reprogramming through an ATG7-independent pathway
    446. Halofuginone reduces the inflammatory responses of DSS-induced colitis through Metabolic reprogramming
    447. Mitochondria/Metabolic reprogramming in the formation of neurons from peripheral cells: cause or consequence and the implications to their utility
    448. PTEN elevation, autophagy and Metabolic reprogramming may be induced in human chondrocytes during steroids or nutrient depletion and osteoarthritis
    449. Metabolic reprogramming as a continuous changing behavior of tumor cells
    450. Eigenvalues of Jacobian matrices report on steps of Metabolic reprogramming in a complex plant-environment interaction
    451. … salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into Metabolic reprogramming of cancer cell …
    452. Metabolic reprogramming in cancer–a coordinated effort
    453. TFmeta: A machine learning approach to uncover transcription factors governing Metabolic reprogramming
    454. MicroRNA regulating Metabolic reprogramming in tumor cells: New tumor markers
    455. Metabolic reprogramming of pyruvate dehydrogenase is essential for the proliferation of glioma cells expressing mutant IDH1
    456. Does a similar Metabolic reprogramming occur in fe-deficient plant cells and animal tumor cells?
    457. A multi-omics analysis reveals Metabolic reprogramming in THP-1 cells upon treatment with the contact allergen DNCB
    458. PD-1 induces Metabolic reprogramming of activated T cells from glycolysis to lipid oxidation
    459. Loss of photosynthesis signals a Metabolic reprogramming to sustain sugar homeostasis during senescence of green leaves: Role of cell wall hydrolases
    460. c-Myc and AP4: a relay team for Metabolic reprogramming of CD8+ T cells
    461. Targeting Metabolic reprogramming as an anti-cancer strategy: aiming at monocarboxylate transporters
    462. Metabolic reprogramming and Hyaluronan Production in Cancer Stem Cells
    463. Metabolic reprogramming via targeting CD38 NADase augments adoptive T cell therapy
    464. Rab27B-Mediated Metabolic reprogramming Induces Secretome Acidification and Chemoresistance in Breast Cancer Cells
    465. Metabolic reprogramming in resting and activated immune cells
    466. Is age-related failure of Metabolic reprogramming a principal mediator in idiopathic Parkinson’s disease? Implications for treatment and inverse cancer risk
    467. NANOG-dependent Metabolic reprogramming and symmetric division in tumor-initiating stem-like cells
    468. reprogramming of basic Metabolic pathways in microbial sepsis: therapeutic targets at last?
    469. Chlamydia Anti-apoptosis–A By-product of Metabolic reprogramming?
    470. NRF2 orchestrates the Metabolic shift during induced pluripotent stem cell reprogramming
    471. Metabolic reprogramming induced by inhibition of SLC2A1 suppresses tumor progression in lung adenocarcinoma
    472. The role of protein conformational switches in pharmacology: its implications in Metabolic reprogramming and protein evolution
    473. FLCN: A new regulator of AMPK-dependent Warburg Metabolic reprogramming
    474. Metabolic reprogramming of T cells in RA
    475. Translating Metabolic reprogramming into new targets for kidney cancer
    476. Targeting cancer with tumor-specific therapeutic strategies–Metabolic reprogramming beyond the Warburg effect
    477. ERRs mediate a Metabolic switch required for somatic cell reprogramming to pluripotency
    478. P080 C-reactive protein: not only a marker, but also a cause of inflammation through Metabolic reprogramming of human macrophages
    479. p110α Hot Spot Mutations E545K and H1047R Exert Metabolic reprogramming Independently of p110α Kinase Activity
    480. CDC5L drives FAH expression to promote Metabolic reprogramming in melanoma
    481. The role of the GABA shunt in prostate cancer Metabolic reprogramming and aggressive phenotype
    482. Metabolic reprogramming after left ventricular assist device: remodeling without recovery of cardiac energetics
    483. The role of 6-phosphofructo-2-kinase (PFK-2)/fructose 2, 6-bisphosphatase (FBPase-2) in Metabolic reprogramming of cancer cells.
    484. Regulation of SIRT3 signal related Metabolic reprogramming in gastric cancer
    485. Wheat resistance to blast using a non-host selective toxin and host Metabolic reprogramming through a successful infection by Pyricularia oryzae
    486. Corrigendum: Metabolic reprogramming During Multidrug Resistance in Leukemias
    487. Highly time-resolved Metabolic reprogramming toward differential levels of phosphate in Chlamydomonas reinhardtii
    488. Elucidating the Metabolic plasticity of cancer: mitochondrial reprogramming and hybrid Metabolic states
    489. Role of oncogenes and tumor suppressors in Metabolic reprogramming and cancer therapeutics: A review
    490. Mitochondrial VDAC1 silencing leads to Metabolic rewiring and the reprogramming of tumour cells into advanced differentiated states
    491. Translational and HIF-1a-Dependent Metabolic reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides
    492. reprogramming microbial Metabolic pathways
    493. Transcriptional reprogramming of Metabolic pathways in critically ill patients
    494. Lactate dehydrogenase acetylation adds another piece to the puzzle of Metabolic reprogramming in pancreatic cancer
    495. Metabolic reprogramming of triple-negative breast cancer: The role of miRNAs
    496. Molecular basis of glucose Metabolic reprogramming in cancer cells
    497. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal
    498. Metabolic reprogramming of human lung cancer cells and ex vivo tissues revealed by UHR-FTMS analysis of small amino and carboxyl metabolites
    499. Adaptive reprogramming of de novo pyrimidine synthesis is a Metabolic vulnerability in triple-negative breast cancer
    500. Metabolic reprogramming in KRAS mutant cancer cells may cause sensitivity to the histone deacetylase (HDAC) inhibitor romidepsin
    501. Using genetics, epigenetics and small molecules to reverse Metabolic reprogramming in adventitia fibroblasts for pulmonary hypertension therapy
    502. Metabolic reprogramming by KSHV in cellular transformation
    503. Metabolic reprogramming of myeloid-derived suppressive cells
    504. The role of macrophages in repair of injured myocardium and perspectives of Metabolic reprogramming of immune cells for myocardial post-infarction recovery
    505. Metabolic reprogramming of Acute Myeloid Leukemia Blasts By Bone Marrow Stroma Cells
    506. Adenosine signaling-mediated Metabolic reprogramming regulates erythropoiesis
    507. Metabolic reprogramming evoked by nitrosative stress enhances the effect of radiation in brain metastases.
    508. Nrf2 promotes esophageal cancer cell proliferation via Metabolic reprogramming and ROS detoxification
    509. X-ray irradiation induces mitophagy and cancer Metabolic reprogramming
    510. Mitochondrial Complex I inhibitor IACS-010759 reverses the NOTCH1-driven Metabolic reprogramming in T-ALL via blockade of oxidative phosphorylation …
    511. Data in support of Metabolic reprogramming in transformed mouse cortical astrocytes: A proteomic study
    512. LSC-2017-A critical role for mTOR regulated Metabolic reprogramming during TGF-β induced fibroblast collagen synthesis
    513. α-ketoglutarate orchestrates macrophage activation through Metabolic and epigenetic reprogramming
    514. An in vivo study into the Metabolic reprogramming of hepatocellular carcinoma
    515. Metabolic reprogramming of the cell: investigating systemic signatures and growth in cancer
    516. Metabolic reprogramming of Myeloid Cells in Response to Factors of “Emergency” Myelopoiesis by Myeloid-Specific PD-1 Ablation, Regulates Myeloid Lineage Fate …
    517. Inhibition of Metabolic reprogramming by zerumbone alters the tumorigenic potential of hepatocellular cancer
    518. Integrated energetics and flux analysis reveals differential Metabolic reprogramming in highly and less invasive cancer cells.
    519. Nutrient stress via folic acid modulation causes systemic and cancer-specific Metabolic reprogramming and differential effects on primary and metastatic mammary …
    520. … Stretch Combines With Adventitial Fibroblast-Derived Signals To Promote Macrophage Activation Through Metabolic reprogramming In Vascular Remodeling
    521. Receptor for advanced glycation end products (RAGE) regulates Metabolic reprogramming induced over-proliferation in pulmonary hypertension
    522. Conserved virulence-linked Metabolic reprogramming in Clostridioides difficile identified through
    523. Metabolic reprogramming Overcomes T Cell Inhibition By AML Cells
    524. Effect of Metabolic reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells
    525. Metabolic switching and cell fate decisions: implications for pluripotency, reprogramming and development
    526. Tyrosine nitration induces a Metabolic reprogramming in neurofibromatosis type 2-associated Schwannoma cells
    527. TORquing Metabolic reprogramming in cancer cells
    528. PO-245 Fructose supports tumour growth and aggressiveness through a Metabolic reprogramming in prostate cancer
    529. CBMT-32. IMAGING A HALLMARK OF CANCER: TERT EXPRESSION LEADS TO MRS-DETECTABLE Metabolic reprogramming
    530. Metabolic reprogramming in cancer cells
    531. reprogramming of proline and glutamine metabolism contributes to the proliferative and Metabolic responses regulated by oncogenic transcription factor c-MYC
    532. Metabolic reprogramming by 3-Iodothyronamine
    533. Computational Analysis of Metabolic reprogramming in Tumors
    534. Ibrutinib-Resistant Mantle Cell Lymphoma Undergoes Metabolic reprogramming Towards Oxphos
    535. Exploring Cancer Cell Plasticity: Epithelial-Mesenchymal Transition and Metabolic reprogramming
    536. Metabolic reprogramming and Epigenetic Regulation in Renal Cell Carcinoma
    537. Metabolic reprogramming in ovarian cancer
    538. The role of Metabolic reprogramming in-herpesvirus-associated oncogenesis
    539. Characterization of intracellular Metabolic states in the origin of the Metabolic reprogramming of cancer cells
    540. HSP90 Facilitates Oncogene-Induced Metabolic reprogramming in B-Cell Lymphomas
    541. Electron transfer dictates Metabolic reprogramming in proliferating cells under hypoxia
    542. Metabolic reprogramming in Cancer and Metabolic Theory of CSC
    543. Metabolic and transcriptional reprogramming in developing soybean (Glycine max) embryos
    544. S-glutathionylation of pyruvate kinase M2 is associated with Metabolic reprogramming and cytokine production in the development of allergic obese airway disease
    545. Transcriptional control of Metabolic reprogramming by the Max-Mlx Network
    546. SAT0012 C-reactive protein: not only a marker, but also a cause of inflammation through Metabolic reprogramming of human macrophages
    547. Age-associated Metabolic reprogramming, oxidative stress response, and cancer progression
    548. Metabolic reprogramming cures liver disease
    549. Understanding Tumour Metabolic reprogramming with Metabolomics
    550. Treatment targeting the Metabolic reprogramming of cancers
    551. TGF-β1 signaling remodels TH17 cell chromatin architecture for Metabolic reprogramming
    552. Studying tumor Metabolic reprogramming through integration of metabolomics and transcriptomics
    553. Exploring Cancer Metabolic reprogramming through Molecular Imaging
    554. Role of PD-L1 immunoregulatory protein in breast cancer cells Metabolic reprogramming
    555. Abstract IA06: Molecular mechanisms of lung cancer development: Between Metabolic reprogramming and genomic instability in the field of cancerization
    556. Metabolic reprogramming in gastric cancer
    557. Reciprocal Metabolic reprogramming through Lactate Shuttle
    558. Adenosine A2B Receptor Controls Erythroid Lineage Commitment in Stress Erythropoiesis By Promoting Metabolic reprogramming
    559. Metabolic reprogramming by hydrogen sulfide
    560. Metabolic reprogramming by the Hexosamine Pathway and N-acetylglucosaminyltransferase
    561. EXTH-64. IMIPRIDONES CAUSE Metabolic reprogramming AND ELICIT UNIQUE VULNERABILITIES IN PRECLINICAL MODEL SYSTEMS OF …
    562. Targeting fructose-induced Metabolic reprogramming in liver metastasis
    563. NAD-Mediated Metabolic reprogramming Epigenetically Regulates Gene Expression to Promote Preadipocyte Differentiation
    564. TUMOR MICROENVIRONMENT INDUCES Metabolic reprogramming IN CANCER CELLS
    565. Suppression of SIRT2 and altered acetylation status of human pluripotent stem cells: possible link to Metabolic switch during reprogramming
    566. Transcription factor bZIP11 mediates Metabolic reprogramming
    567. Systems biology approach in understanding Metabolic reprogramming in breast cancer.
    568. Metabolic reprogramming of Dendritic Cells Is Controlled By the Mir-142
    569. Activation of Lxrβ Causes Metabolic reprogramming and Sensitizes Solid Tumors to Bcl-xL Inhibition Mediated Apoptosis
    570. Metabolic reprogramming of Stem Cell Epigenetics
    571. Phosphatase of Regenerative Liver-2 mediates cellular Metabolic reprogramming in breast cancer
    572. Elucidation of the role of Metabolic reprogramming in osteoclast differentiation
    573. The effect of immunosuppressive molecules on T-cell Metabolic reprogramming
    574. Cell fate and Metabolic reprogramming of tumor-initiating stem-like cells
    575. Lipid Metabolic reprogramming drives resistance to PD1 blockage
    576. Metabolic reprogramming with a Long Noncoding RNA
    577. HEME OXYGENASE-1 AND Metabolic reprogramming IN RESPONSE TO ISCHEMIA
    578. INNOVATIVE MEDICINE FOR Metabolic reprogramming OF INTRACTABLE CANCER STEM CELLS
    579. reprogramming a maize plant: transcriptional and Metabolic changes induced by the fungal biotroph Ustilago maydis
    580. METB-01 Metabolic reprogramming during resistance to anti-angiogenic therapy
    581. SIRT5 in cancer Metabolic reprogramming
    582. Cell intrinsic regulation of B cell activation: Metabolic reprogramming and mitochondrial remodelling
    583. CYTOPROTECTION AND Metabolic reprogramming GOVERNED BY KEAP1-NRF2 SYSTEM
    584. Abstract LB-198: Molecular drivers of Metabolic reprogramming during EMT
    585. Metabolic reprogramming in non-small cell lung cancer: a precision oncology approach
    586. Metabolic reprogramming may underpin the aetiology of endometriosis
    587. Analyzation of Metabolic reprogramming in Drug-Resistant MCF-7 Cells
    588. Tumor Cell Metabolic reprogramming and Drug Targeting
    589. Understanding the role of Metabolic reprogramming in breast cancer progression and metastasis
    590. Metabolic reprogramming upon CD8 T cell activation
    591. The role of Metabolic reprogramming in breast cancer progression and metastasis
    592. Metabolic reprogramming of Pancreatic Ductal Adenocarcinoma Cells in Response to Chronic Low pH Stress
    593. Vitamin E deficiency causes a Metabolic reprogramming dysregulating cellular energy homeostasis
    594. Targeting Lipid Metabolic reprogramming as Anticancer Therapeutics
    595. Metabolic reprogramming of myeloid cells during tumor progression
    596. OP0027 Abnormal B Cell Activation through Cellular Metabolic reprogramming and Its Relevance To The Pathogenesis of SLE
    597. Decoding Metabolic reprogramming by the AMPK pathway in cancer and Metabolic disease
    598. Human melanoma exosomes induce Metabolic reprogramming in human adult dermal fibroblasts
    599. Sirtuins in Cancer–Emerging Role as Modulators of Metabolic reprogramming
    600. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma Metabolic reprogramming: Trichostatin A as a case study
    601. Metabolic reprogramming of oestrogen receptor positive breast cancer in endocrine therapy resistance
    602. Role of oncogene and tumor suppressor gene in tumor Metabolic reprogramming
    603. Metabolic reprogramming of the de novo fatty acid synthesis pathway in cancer devel-opment and progression
    604. Epithelial-Mesenchymal Transition and Metabolic reprogramming in Human Breast Cancer Cells
    605. Cigarette smoke induces Metabolic reprogramming in lung cells
    606. Abstract IA07: Metabolic reprogramming by MYC: Lessons learned from adenovirus
    607. CREB orchestrates Metabolic reprogramming in PDGFRA-addicted lung squamous cell cancer
    608. The Role of Acetylation in the Metabolic reprogramming of Cancer Cells
    609. PI3K-directed Metabolic reprogramming in thyroid cancer
    610. L-Asparaginase Causes Metabolic reprogramming in ALL Cells
    611. HSP90 Facilitates Oncogene-Induced Metabolic reprogramming in B-Cell Lymphomas
    612. Metabolic reprogramming by an epigenetic mechanism in endocrine therapy resistance of breast cancer
    613. Metabolic reprogramming of Macrophages Exposed to Pseudomonas aeruginosa Biofilm
    614. Metabolic reprogramming as therapeutic strategy to ameliorate skeletal muscle tissue engineering procedures
    615. Induction of differentiation and Metabolic reprogramming in human hepatoma cells by adult human serum
    616. Fueling immunity: The role of Myc in Metabolic reprogramming of activated T cells
    617. LSD1 mediates Metabolic reprogramming by glucocorticoids during myogenic differentiation
    618. Aldehyde Metabolic reprogramming in oesophageal adenocarcinoma
    619. Arsenic-induced Metabolic reprogramming: A Role for Autophagy, NRF2, and OGlcNAcylation
    620. Radiosensitization of Glioblastoma Stem Cells through Targeting Metabolic reprogramming
    621. Mitochondrial bioenergetic function and Metabolic plasticity in stem cell differentiation and cellular reprogramming
    622. Metabolic reprogramming of radiation fibrosis using adipose derived stromal cells
    623. Propofol induces Metabolic reprogramming and cell death in a mitochondrial electron transport chain-dependent manner
    624. SF3B1 mutations induce proteome remodeling, Metabolic reprogramming, and a novel kind of tumor surface antigen in human cells
    625. PPARαAntagonist AA452 Triggers Metabolic reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells
    626. Metabolic reprogramming In Pulmonary Hypertension As Gleaned Through Mass Spectrometry-Based Metabolomics
    627. Metabolic reprogramming discriminates aggressive vs. slowly growing preneoplastic lesions at early stages of HCC development
    628. Abstract A02: The epigenetic modifier CHAF1A opposes neuroblastoma differentiation via Metabolic reprogramming
    629. Branched-Chain Amino Acid Metabolic reprogramming in Heart Failure
    630. Targeting Metabolic reprogramming associated to cancer cells: search of novel targets and combined therapies in cancer treatment
    631. reprogramming Metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
    632. Metabolic reprogramming of lignin biosynthesis in crops
    633. Glucose-dependent Metabolic reprogramming in HDAC5-depleted cancer cells
    634. Mitochondrial Metabolic reprogramming of Melanoma Cells Exposed to BRAFV600E Inhibitor
    635. PUB014 Collagen XVII Activates Oct4 and Alters Metabolic reprogramming through Upregulation of AKT/GSK-3β/β-catenin Pathway in Lung Cancer
    636. Reciprocal Metabolic reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay
    637. Implicating Glucagon-like peptide-1 in the hormone-dependent Metabolic reprogramming observed in advanced prostate cancer
    638. Where do root exudates come from? Metabolic reprogramming under nutrient deficiency: Fe nutrition as a case study
    639. Adrenergic signaling impairs activation of CD8+ T cells by blocking Metabolic reprogramming
    640. Abstract SY01-02: Autophagy and Metabolic reprogramming in the tumor stroma
    641. Metabolic reprogramming in EMT-targeting regulatory nodes in mesenchymal cells
    642. Metabolic reprogramming in Mutant KRAS Colorectal Cancer Cells
    643. Abstract NG08: Transcriptional mechanisms for autophagy regulation and Metabolic reprogramming in pancreatic cancer
    644. Abstract B44: The epigenetic modifier CHAF1A opposes neuroblastoma differentiation via Metabolic reprogramming
    645. Epigenetic and Metabolic reprogramming as a target for prostate tumor radiosensitization
    646. mTORC1-dependent Metabolic reprogramming orchestrates T cell activation and fate decisions (IRM10P. 750)
    647. Evidence that the AMPK activator, Metformin, induced protection of the retina and RPE through Metabolic reprogramming
    648. A role for Noxa in human primary T cell activation and Metabolic reprogramming (LYM4P. 756)
    649. Curcumin Inhibit the proliferation of Ec109 cells via Metabolic reprogramming
    650. Abstract A99: Posttranscriptional gene regulation by HuR can explain Metabolic reprogramming in acutely stressed pancreatic cancer cells.
    651. Adipose tissue FABP deficiency promotes Metabolic reprogramming and positively impacts healthspan
    652. Propofol induces Metabolic reprogramming and cell death in a mitochondrial electron transport chain-dependent manner
    653. Isotopic tracing technique in quantitative analysis of Metabolic reprogramming in tumor cells
    654. Role of SIRT6 in Metabolic reprogramming During Colorectal Carcinoma
    655. Abstract SY22-02: Tumor suppression by p62 through the Metabolic reprogramming of the stroma
    656. Stromal epigenetic alterations drive Metabolic and neuroendocrine prostate cancer reprogramming
    657. New insights in the regulation of mitochondrial functions and Metabolic reprogramming by ERBB receptors in cancer
    658. Hepatic Metabolic reprogramming by Caloric Restriction in Rhesus Monkeys
    659. Metabolic reprogramming caused by mutations of the Fbw7 ubiquitin ligase in colorectal cancer
    660. Protein Kinase C-bDictates B Cell Fate by Regulating Mitochondrial Remodeling, Metabolic reprogramming, and Heme Biosynthesis
    661. Exportin-1 enables pro-tumorigenic Metabolic reprogramming of lung fibroblasts through relocalization of p53 and p62/SQSTM1
    662. Paracoccidioides brasiliensis presents Metabolic reprogramming and secretes a serine proteinase during murine infection Laurine Lacerda Pigosso1, Lilian …
    663. An insight into sono-activated nanoliposomes-mediated Metabolic reprogramming in liver of tumor-bearing mice
    664. Abstract B28: Multiplexed mass spectrometry analysis of KRAS-associated Metabolic reprogramming in colorectal tumors and cell lines